Biomedical Engineering: Scope, Practice, and Applications

Biomedical engineering applies engineering principles and design concepts to medicine and biology, producing technologies that range from implantable cardiac devices to diagnostic imaging systems. The field sits at the intersection of the life sciences, clinical medicine, and multiple engineering disciplines, making it one of the most structurally complex practice areas in the broader engineering landscape. Regulatory oversight from the U.S. Food and Drug Administration (FDA) governs the majority of commercial biomedical products, and the discipline's practitioners must navigate both engineering standards and federal health law.

Definition and Scope

Biomedical engineering (BME) is defined by the Accreditation Board for Engineering and Technology (ABET) as an engineering discipline that advances health and healthcare by applying engineering methods to problems in biology and medicine. ABET accredits undergraduate and graduate BME programs against criteria that require coursework spanning physiology, transport phenomena, biomechanics, biomaterials, and instrumentation.

The field breaks into at least 8 recognized sub-disciplines, each with distinct technical focus areas:

1. Biomechanics — analysis of forces on and within biological structures; applied in orthopedic implant design and prosthetics.
2. Biomaterials — development of synthetic and natural materials compatible with living tissue, governed by ISO 10993 biocompatibility standards.
3. Biomedical instrumentation — design of sensors, monitors, and diagnostic equipment including electrocardiographs and pulse oximeters.
4. Medical imaging — engineering of MRI, CT, ultrasound, and nuclear medicine systems; signal processing is a core competency.
5. Tissue engineering and regenerative medicine — scaffold-based and cell-based strategies to repair or replace damaged tissue.
6. Clinical engineering — management and maintenance of medical equipment within healthcare facilities; practitioners often hold certification through the American College of Clinical Engineering (ACCE).
7. Rehabilitation engineering — assistive technology design for individuals with disabilities, intersecting with interdisciplinary engineering approaches.
8. Neural engineering — brain-computer interfaces, neural prosthetics, and deep brain stimulation systems.

The FDA classifies medical devices into three classes (I, II, III) under 21 CFR Parts 862–892, with Class III devices — including implantable pacemakers and neurostimulators — requiring the most rigorous Premarket Approval (PMA) process.

How It Works

Biomedical engineering projects follow a structured development cycle that parallels general engineering design process frameworks but incorporates biocompatibility and regulatory checkpoints absent in other disciplines.

Phase 1 — Needs Assessment and Clinical Input
Clinical collaborators define functional and safety requirements. Standards such as IEC 60601-1 (medical electrical equipment safety) and ISO 14971 (risk management for medical devices) frame early design constraints. ISO 14971 is published by the International Organization for Standardization and directly referenced by FDA guidance documents.

Phase 2 — Feasibility and Concept Design
Prototype concepts are evaluated against biological constraints. Finite element analysis (FEA) and computational fluid dynamics (CFD) are standard in biomechanics and cardiovascular device work, tools addressed broadly under engineering analysis and modeling methods.

Phase 3 — Verification and Validation (V&V)
The FDA distinguishes between verification (does the device meet design specifications?) and validation (does it meet user needs in the intended environment?). Both processes must be documented in a Design History File (DHF) under 21 CFR Part 820.

Phase 4 — Regulatory Submission
510(k) clearance applies to devices substantially equivalent to a legally marketed predicate device. PMA applies to Class III devices without a predicate. The FDA's Center for Devices and Radiological Health (CDRH) administers both pathways.

Phase 5 — Post-Market Surveillance
Manufacturers must maintain post-market surveillance systems. The FDA's MedWatch program and the Manufacturer and User Facility Device Experience (MAUDE) database collect adverse event reports.

Common Scenarios

Biomedical engineers operate across four primary professional environments:

• Medical device manufacturers — The U.S. medical device industry employed approximately 338,000 workers as of the Bureau of Labor Statistics, Occupational Outlook Handbook 2022 data. Engineers in this setting focus on product design, testing, and regulatory affairs.
• Hospitals and health systems — Clinical engineers manage device procurement, maintenance, and safety compliance. The Joint Commission standards require documented equipment management programs.
• Academic and government research — The National Institutes of Health (NIH) and the National Science Foundation (NSF) are the primary federal funders of basic biomedical engineering research. NIH's National Institute of Biomedical Imaging and Bioengineering (NIBIB) was established specifically to support this intersection of fields.
• Regulatory bodies and consulting — Engineers work within or alongside the FDA's CDRH, or independently as consultants supporting 510(k) and PMA submissions.

Decision Boundaries

Biomedical engineering diverges from adjacent disciplines along clear structural lines:

BME vs. Biomedical Technology/Technician roles — Engineers hold four-year or advanced degrees and engage in design and development; biomedical equipment technicians (BMETs) typically hold associate degrees and focus on maintenance and repair. The Association for the Advancement of Medical Instrumentation (AAMI) and ACCE define these role boundaries.

BME vs. Chemical Engineering in Pharma — While chemical engineers work extensively in pharmaceutical manufacturing under FDA's 21 CFR Part 210/211 (drug GMPs), biomedical engineers concentrate on devices, implants, and biological systems rather than drug molecules. The two paths intersect in drug-device combination products.

Licensure — Professional Engineer (PE) licensure through the National Council of Examiners for Engineering and Surveying (NCEES) is available to biomedical engineers and may be required for certain public-sector roles, though it is less universally mandated in this field than in civil or structural practice. Full context on licensure requirements appears at Engineering Licensure and Certification (US).

Scope vs. Emerging fields — Neural engineering and synthetic biology represent boundaries where biomedical engineering overlaps with emerging engineering fields, and credentialing standards in those areas remain less codified than in device-focused subspecialties.